Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Global Blood Ther (NQ: GBT ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 4, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Global Blood Ther < Previous 1 2 3 4 Next > Biotech Stocks Well-Positioned For The Fourth Quarter October 12, 2022 The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far. Via Talk Markets These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 September 20, 2022 We have used the August return data from finviz.com to come up with the five best and worst performing mid-cap stocks in August 2022. Via Talk Markets Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin September 15, 2022 The market is struggling, yet biotech stocks are acting like it's good times again. Here's why. Via Investor's Business Daily Global Blood Therapeutics's Return On Capital Employed Overview September 15, 2022 Benzinga Pro data, Global Blood Therapeutics (NASDAQ:GBT) reported Q2 sales of $71.55 million. Earnings fell to a loss of $82.47 million, resulting in a 1.29% decrease from last quarter. Via Benzinga Where Global Blood Therapeutics Stands With Analysts August 09, 2022 Within the last quarter, Global Blood Therapeutics (NASDAQ:GBT) has observed the following analyst ratings: Via Benzinga Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics August 08, 2022 The deal adds to Pfizer's efforts to tackle sickle cell disease. Via Investor's Business Daily Pfizer Scoops Up Sickle Disease Player For $5B August 08, 2022 Via Benzinga Global Blood Therapeutics's Return On Capital Employed Overview September 01, 2022 Global Blood Therapeutics (NASDAQ:GBT) brought in sales totaling $71.55 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 1.29%, resulting in a loss of $82.47... Via Benzinga After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal September 01, 2022 Via Benzinga GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT August 31, 2022 From Kahn Swick & Foti, LLC Via Business Wire 10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others August 29, 2022 These names are benefitting from M&A, clinical data and promising regulatory actions. Via Investor's Business Daily Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million August 23, 2022 The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie. Via Investor's Business Daily Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review August 12, 2022 The major indexes continued to advance, despite some key warnings. Via Investor's Business Daily Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US August 09, 2022 Via Benzinga 8 Analysts Have This to Say About Global Blood Therapeutics August 09, 2022 Within the last quarter, Global Blood Therapeutics (NASDAQ:GBT) has observed the following analyst ratings: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022 August 09, 2022 Via Benzinga Global Blood Therapeutics: Q2 Earnings Insights August 08, 2022 Global Blood Therapeutics (NASDAQ:GBT) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga GLOBAL BLOOD THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Global Blood Therapeutics, Inc. - GBT August 08, 2022 From Kahn Swick & Foti, LLC Via Business Wire Why These Pfizer Analysts Like The Global Blood Therapeutics Deal August 08, 2022 Pfizer Inc. (NYSE: PFE) shares were trading lower Monday after the drugmaker announced a $5.4-billion bid to acquire blood disorder drugmaker Global Blood Therapeutics Inc (NASDAQ: GBT). Via Benzinga TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week August 08, 2022 Short squeeze stocks are still a hot topic this week and we're listing five of the shares investors will want to keep an eye on! Via InvestorPlace GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics August 08, 2022 GBT stock is already rallying on takeover talk. Now that Pfizer has confirmed the buyout, Global Blood Therapeutics is red hot. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022 August 08, 2022 Via Benzinga Global Blood (GBT) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Global Blood Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – GBT August 08, 2022 From Halper Sadeh LLP Via Business Wire Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8 August 08, 2022 CNBC Celsius Withdraws Motion To Rehire CFO Via Benzinga iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday August 08, 2022 U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. Via Benzinga Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday August 08, 2022 Gainers Via Benzinga Small Cap Biotechs Perk Up On Dealmaking August 06, 2022 With M&A picking up we would think smaller deals make sense for large cap biopharma to expand pipelines and complement technology. Via Talk Markets 12 Health Care Stocks Moving In Friday's Intraday Session August 05, 2022 Via Benzinga A Preview Of Global Blood Therapeutics's Earnings August 05, 2022 Global Blood Therapeutics (NASDAQ:GBT) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga Pfizer Is Reportedly In 'Advanced Talks' To Buy Global Blood Therapeutics For $5 Billion August 05, 2022 Shares of Pfizer's rumored takeover target have rocketed for two days running. Via Investor's Business Daily < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.